EcoDrugPlus

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSMAUG00000012262
Gene Symbol: ALOX5AP
4 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSMAUG00000000787
Gene Symbol: AVPR1B
4 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMAUG00000001098
Gene Symbol: AVPR2
4 Cross references
231 Possible Orthologues:

Aromatase

Ensembl ID : ENSMAUG00000014665
Gene Symbol: LOC101836523
4 Cross references
315 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSMAUG00000018001
Gene Symbol: AHR
2 Cross references
154 Possible Orthologues:

Ataxia Telangiectasia And Rad3 Related

Ensembl ID : ENSMAUG00000013539
Gene Symbol: ATR
1 Cross references
206 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSMAUG00000008679
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMAUG00000019977
Gene Symbol: AURKB
4 Cross references
205 Possible Orthologues:

Aurora Kinase C-Like

Ensembl ID : ENSMAUG00000017266
Gene Symbol: LOC101832350
2 Cross references
90 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSMAUG00000009225
Gene Symbol: LOC101842857
2 Cross references
180 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSMAUG00000001253
Gene Symbol: BDKRB2
4 Cross references
356 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSMAUG00000013345
Gene Symbol: BCHE
4 Cross references
130 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).